Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Jently vs Kongo

Jently
Graded #178

Lower grade

vs+16.799999999999997
Kongo
Graded #27

Higher grade

The verdict

Kongo takes it — 83.8/100 to 67/100.

Kongo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Cheap semaglutide ($119) but a steeper tirzepatide step-up ($229); verified, nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKongo +12
74
86
Dose & formulationKongo +16
64
80
Clinical oversightKongo +5
79
84
Labs & monitoringKongo +30
52
82
FulfillmentKongo +20
67
87
Contract termsKongo +34
51
85
Jently · left barKongo · right bar

The numbers

MetricJentlyKongo
WeighScore67/10083.8/100
GradeCB
Scorecard rank#178#27
Semaglutide$149/mo (starting dose, compounded)$119/mo
Tirzepatide$199/mo (starting dose, compounded)$229/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Jently

Graded #178 · C

Strengths

  • Compounded semaglutide from $149/mo and tirzepatide from $199/mo — pricing published
  • Multi-pillar: GLP-1, NAD+, peptides (sermorelin, glutathione), and metformin
  • 100% online with licensed providers via the MD Integrations network
  • Subscription can be cancelled anytime through the patient portal

Where it loses points

  • Specific pharmacy partner not named on the site
  • No refunds once a consultation is completed or a prescription is dispensed
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published
Kongo

Graded #27 · B

Strengths

  • $119 semaglutide
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Tirzepatide jumps to $229/mo
  • Injection-only
  • Monitoring detail sparse

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard